a novel approach in the treatment of neuroendocrine gastrointestinal tumors additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine一个新颖的方法治疗胃肠道神经内分泌肿瘤添加剂interferon-γ和meta-iodobenzylguanidine抗增殖的影响.pdfVIP

a novel approach in the treatment of neuroendocrine gastrointestinal tumors additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine一个新颖的方法治疗胃肠道神经内分泌肿瘤添加剂interferon-γ和meta-iodobenzylguanidine抗增殖的影响.pdf

  1. 1、本文档共14页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a novel approach in the treatment of neuroendocrine gastrointestinal tumors additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine一个新颖的方法治疗胃肠道神经内分泌肿瘤添加剂interferon-γ和meta-iodobenzylguanidine抗增殖的影响

BMC Cancer BioMed Central Research article Open Access A novel approach in the treatment of neuroendocrine gastrointestinal tumors: Additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine 1 1 1 Michael Höpfner , Andreas P Sutter , Alexander Huether , Gudrun Ahnert- 2 1 Hilger and Hans Scherübl* Address: 1Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin, Medical Clinic I, Hindenburgdamm 30, 12200 Berlin, Germany and 2Charité – Universitätsmedizin Berlin, Campus Mitte, Institut für Anatomie, Philippstrasse 12, 10115 Berlin, Germany Email: Michael Höpfner - michael.hoepfner@charite.de; Andreas P Sutter - andreas.sutter@charite.de; Alexander Huether - alexander.huether@charite.de; Gudrun Ahnert-Hilger - gudrun.ahnert@charite.de; Hans Scherübl* - hans.scherubl@charite.de * Corresponding author Published: 21 May 2004 Received: 22 December 2003 Accepted: 21 May 2004 BMC Cancer 2004, 4:23 This article is available from: /1471-2407/4/23 © 2004 Höpfner et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the articles original URL. Abstract Background: Therapeutic options to effectively inhibit growth and spread of neuroendocrine gastrointestinal tumors are still limited. As both meta-iodobenzylguanidine (MIBG) and inter

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档